Second Circular and Provsional Conference Program
The 3rd International Conference
DNA Vaccines 2007
The Gene Vaccine Conference
23-25 May, Torrequebrada Hotel, Malaga, Spain
Advisory Scientific Panel
Conference Chairman:
David Weiner (University of Pennsylvania, USA)
Maurizio Zanetti (University of California, USA)
Lorne Babiuk (VIDO, Saskatchewan, Canada)
Eyal Raz (University of California, USA)
Jim Robertson (NIBSC, Potters Bar, UK)
Jeffrey Ulmer (Chiron Vaccines, California, USA)
Britta Wahren (Karolinska Institute, Stockholm, Sweden)
Peter Loudon (PowderMed, Oxford, UK)
Freda Stevenson (Tenovus Laboratory, Southampton, UK)
Zhongming Li (Shanghai Biotech, China)
Sidong Xiong (Fudan University, China)
Shan Lu (University of Massachusetts, USA)
DNA VACCINES 2007 is the follow-up meeting to the successful DNA VACCINES conferences held in Edinburgh in October 2002 and Monte Carlo in November 2004.
From an unproven novelty with limited acceptance in the community, DNA or ‘Genetic’ vaccines have arrived as a potent means of providing immune responses or protective immunity against viruses, bacteria and parasites in many species from fish to primates, including human volunteers. DNA vaccines, comprising plasmid DNA encoding proteins from pathogens, allergens, and tumours, are being evaluated as prophylactic vaccines and therapeutic treatments for infectious diseases, allergies and cancer. Plasmids encoding normal human proteins are likewise being tested as vaccines and treatments for autoimmune diseases.
DNA vaccination has become an accepted method in the research community with human trials now in process. The use of DNA as a means of vaccination offers potential benefits in protective efficacy, cross-strain applicability, development speed and manufacturing cost compared with conventional vaccines. DNA vaccines are known to be particularly effective in inducing killer T-cell responses which are an important ingredient in fighting infections.
DNA VACCINES 2007 will follow-up the success of the previous meetings in attracting delegates from the cancer and the infectious disease communities to come together to discuss the ‘common ground’ between these two major groups.
DNA VACCINES 2007 will again be major opportunity for leading researchers to gather and report on the latest cutting edge research currently being undertaken in the progressive field of DNA or Genetic vaccines.
Extended deadline for late-breaking oral abstracts Friday 16th February 2007
Closing date for poster abstract submissions Friday 30th March 2007
Super Platinum Sponsor
Platinum Sponsor
Sponsored by
